CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 61 enrolled
Drug / intervention
Lidocaine +1 moredrug
Likely dose
Lidocaine 4mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01534520
NCT01534520N/ACompleted
CompareCT.gov

Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women: a Randomized Controlled Trial

University of Pittsburgh·interventional·Posted Feb 16, 2012·Updated Dec 22, 2016

In Brief

A clinical study evaluating Lidocaine and Placebo for Pain. Completed, enrolled 61 participants across 1 site.

Detailed Summary

This study is designed to evaluate if self-inserted intravaginal 2% lidocaine gel is effective at decreasing pain during intrauterine device insertion in nulliparous women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsSociety of Family Planning

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 16, 2012
Enrollment StartJun 1, 2012
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.4 years ago

Interventions

Lidocainedrug

Intravaginal insertion of 4mL 2% lidocaine gel

Placebodrug

KY Jelly